Anthem Biosciences Limited (ANTHEM) Share Price
NSE · Healthcare · Biotechnology · ISIN INE0CZ201020
Key metrics
- Market Cap
- ₹51,930 Cr
- P/E Ratio
- 91.63
- EPS
- 10.09
- Book Value
- 54.16
- P/B Ratio
- 16.49
- ROE
- 19.45%
- ROCE
- 22.78%
- Debt / Equity
- 0.02
- Net Margin
- 27.86%
- Revenue Growth
- 15.17%
- Profit Growth
- 31.14%
- Dividend Yield
- 0.22%
- 52W High
- ₹942.60
- 52W Low
- ₹579.15
- Market Cap Band
- large cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Anthem Biosciences Limited
Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients. The company offers contract research development and manufacturing services, such as end-to-end services across the new chemical entity and new biological entity lifecycles, as well as engages in contract research, development, and manufacturing of development batches of molecules used for clinical trials up to commercial manufacturing for small molecules and biologics. It also manufactures and sells specialized fermentation-based active pharmaceutical ingredients, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. The company was incorporated in 2006 and is based in Bengaluru, India.
- Headquarters
- Bengaluru, India
- Employees
- 2,282
- Promoter Holding
- 84.13%
The full Anthem Biosciences Limited analysis
Create a free account to open the complete ANTHEM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.